Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Vaccine|November 8, 2024
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report|October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
Pageof 11